European Journal of Therapeutics最新文献

筛选
英文 中文
Concerns About Co-Authoring AI Tools in Academic Papers 对学术论文中人工智能工具合著的担忧
IF 0.3
European Journal of Therapeutics Pub Date : 2023-09-09 DOI: 10.58600/eurjther1836
Emrah Yildiz
{"title":"Concerns About Co-Authoring AI Tools in Academic Papers","authors":"Emrah Yildiz","doi":"10.58600/eurjther1836","DOIUrl":"https://doi.org/10.58600/eurjther1836","url":null,"abstract":"Dear Editors\u0000With great attention and interest, I read the editors’ short brief yet thought-provoking editorials [1,2] and it has helped me combine valuable information with my research and experiences. Today, artificial intelligence has become an application that we can use in all areas of our lives, being versatile, and able to analyze, collect and interpret. Writing ChatGPT that we can barely bring together for weeks or even months of work, and other AI applications can be used in minutes or even. We seconds can see that it produces original writings and offers a wide range of information. It is obvious that the time-saving experience provided by artificial intelligence provides convenience in most areas of our lives. But that's human researchers and artificial intelligence it may cause us to not understand some points about certain differences between the two. For example, when we look at the difference between an article written with artificial intelligence and an article written with human intelligence, it is undoubtedly almost understandable at first glance impossible.\u0000Because of life's developing and changing conditions, no field wanted to be left behind and turned to itself to build its essence, one of which is undoubtedly artificial Intelligence. With the rapid progression of the COVID-19 pandemic and swiftly evolving political decisions, technology has become exceedingly practical and adaptive, undergoing continuous transformation.\u0000Many research studies have begun to be conducted around the world, with the need for individuals to conduct faster and more extensive research to bring together new and diverse resources.\u0000While the utilization of artificial intelligence (AI) appears as one of the most promising options for this purpose, we must inquire whether its inclusion as a co-author adheres to ethical and technical standards or if it occasionally neglects these principles.\u0000In my opinion, involving AI tools like ChatGPT as a co-author can potentially lead to ethical complexities, especially in terms of responsibility and accountability.\u0000Language models powered by artificial intelligence lack consciousness, autonomy, and the ability to claim ownership of their contributions. Ascribing authorship to these models blurs lines of responsibility and weakens the ethical obligations inherent in scholarly authorship. Simultaneously, the essence of scholarly authorship lies in the generation of hypotheses, experimentation, data analysis, and interpretation, attributes ascribed to individuals who actively contribute. In this context, even though ChatGPT and other artificial intelligence models expeditiously furnish us with desired information through rapid interactions, it is fundamentally derived from existing human input sources. In essence, these AI systems do not so much transform or recreate a wellspring of knowledge as they present it in its preexisting state. Introducing ChatGPT as a co-author could evoke the assumption of its active engage","PeriodicalId":42642,"journal":{"name":"European Journal of Therapeutics","volume":"9 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2023-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75837037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma Leptin, Nesfatin 1, NPY, and Zinc Levels in Obese and Metabolic Syndrome Children 肥胖和代谢综合征儿童血浆瘦素、Nesfatin 1、NPY和锌水平
European Journal of Therapeutics Pub Date : 2023-09-09 DOI: 10.58600/eurjther1760
Adnan Aydogdu, Omer Unal, Saltuk Bugra Baltaci, Esma Menevse, Rasim Mogulkoc, Said Sami Erdem, Muammer Buyukinan, Abdulkerim Kasim Baltaci
{"title":"Plasma Leptin, Nesfatin 1, NPY, and Zinc Levels in Obese and Metabolic Syndrome Children","authors":"Adnan Aydogdu, Omer Unal, Saltuk Bugra Baltaci, Esma Menevse, Rasim Mogulkoc, Said Sami Erdem, Muammer Buyukinan, Abdulkerim Kasim Baltaci","doi":"10.58600/eurjther1760","DOIUrl":"https://doi.org/10.58600/eurjther1760","url":null,"abstract":"Objective: The aim of this study is to investigate the relationship between leptin, nesfatin 1 and NPY hormones and zinc in boys and girls diagnosed with metabolic syndrome and obesity. Materials and Methods: This study included a total of 6 groups. Group 1 Boy Control, Group 2 Girl Control, Group 3 Obese Boys, Group 4 Obese Girls, Group 5 Boys with Metabolic Syndrome, Group 2 with Girls with Metabolic Syndrome. Plasma leptin, nesfatin-1, NPY (by ELISA method) and serum zinc (by AA method) levels were determined in blood samples obtained from the subjects. Results: Leptin and zinc levels were significantly higher both in boy and girl patients with metabolic syndrome than in obese and control children. Nesfatin-1 and NPY levels were significantly lower both in girl and boy obese and metabolic syndrome children compared to their control groups. Conclusion: In the current study a significant increase in plasma leptin and serum zinc levels and a significant decrease of plasma nesfatin-1 and NPY levels were observed in boys and girls with metabolic syndrome. The findings of our study show that leptin, nesfatin-1 and NPY levels may be important biomarkers in the assessment of metabolic syndrome risk in both girls and boys.","PeriodicalId":42642,"journal":{"name":"European Journal of Therapeutics","volume":"2016 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136107452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discussion on the Artificial Intelligence (AI) Tools Usage in the Scientific World 人工智能(AI)工具在科学领域的应用探讨
IF 0.3
European Journal of Therapeutics Pub Date : 2023-09-09 DOI: 10.58600/eurjther1837
Mazhar Özkan, H. Sasani
{"title":"Discussion on the Artificial Intelligence (AI) Tools Usage in the Scientific World","authors":"Mazhar Özkan, H. Sasani","doi":"10.58600/eurjther1837","DOIUrl":"https://doi.org/10.58600/eurjther1837","url":null,"abstract":"Dear Editors,\u0000We have been reading with great interest your editorial discussion on “Artificial Intelligence and Co-Authorship” which you initiated some time ago [1]. In the current era, the vast amount of data generated from routine applications, scientific research, and the resulting outcomes has surpassed what the human mind can read and evaluate. Therefore, there has been a need to summarize data and develop information processing-based applications for easy access, leading to the design of automated - artificial intelligence-based - tools. Nowadays, these tools are used in various processes, from data collection and analysis to hypothesis generation, experimentation, and simulation.\u0000The use of Artificial Intelligence (AI) tools is highly beneficial in conducting and reporting scientific research. Particularly, for tasks such as literature reviews, identifying research gaps, and learning about collaborations among researchers/institutions, a wide range of AI-based tools has been developed, making it easier for researchers to accomplish these tasks. However, researchers are still seeking solutions to expedite the time-consuming aspects of writing their research.\u0000AI can automate repetitive tasks efficiently and with minimal errors, allowing humans to focus on more creative and strategic tasks. They can make better decisions by forecasting the future based on evaluating various types of existing data. After analysing similar content, they can generate purposeful creative content. They can answer questions on topics that humans may not understand comprehensively and informatively. And of course, they can translate text and speeches accurately and fluently into other languages.\u0000Misuse of AI tools or misinterpretation of results obtained from these applications can have significantly adverse consequences. One notable example of this is the unchecked preparation of academic papers by AI-based software. In fact, ChatGPT has been listed as a co-author in at least four articles in the literature, but corrections have been made in some cases due to its inaccuracies. When the Web of Science is searched, it is seen that ChatGPT was removed from authorship by making corrections in 1 article in which ChatGPT was previously mentioned as a co-author [2], and in two articles in the British Journalism Review and in three articles about ChatGPT in different journals, it was mentioned as a group author.\u0000It has been observed that while AI models like ChatGPT can generate text that appears human-like, there can be issues with interpretation and the presentation of false references, as highlighted in studies in the literature. Therefore, AI-based software like ChatGPT should not be used as co-authors without control but should be used as tools like other software, with the written text going through human oversight. As a result, the full responsibility for what these AI tools produce should rest with the author(s) submitting the article and cannot be attributed to t","PeriodicalId":42642,"journal":{"name":"European Journal of Therapeutics","volume":"73 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2023-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76440447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast Stereotactic Excision Results 乳房立体定向切除结果
IF 0.3
European Journal of Therapeutics Pub Date : 2023-09-09 DOI: 10.58600/eurjther1825
Zehra Ünal Özdemir, Mehmet Onur Gül
{"title":"Breast Stereotactic Excision Results","authors":"Zehra Ünal Özdemir, Mehmet Onur Gül","doi":"10.58600/eurjther1825","DOIUrl":"https://doi.org/10.58600/eurjther1825","url":null,"abstract":"Objective: Suspicious microcalcifications detected in mammographic examinations may appear as early signs of breast malignancies. Microcalcifications that appear only on mammography and are not accompanied by any ultrasonographic mass should be excised after marking with a stereotactic wire, and pathological examination should be performed. In this study, we aimed to analyze the stereotactic biopsy results and share their findings.\u0000Methods: Lesions with suspicious microcalcifications on mammography (Figure 1) and in which no mass image was detected in the ultrasonographic response were evaluated retrospectively between January 2016 and December 2022. Excision was applied to the patients after marking with mammography and stereotactic wire. Removal of the suspicious microcalcification area was confirmed by radiography of the specimen in all patients. Pathological examination results of the patients, whether re-excision was made, tumor diameter in cases with malignancy, and follow-up periods of the patients were evaluated.\u0000Results: A total of 54 patients who underwent excision due to microcalcification were evaluated in the study. Malignancy was detected in 15 (27.7%) patients. The most common ductal carcinoma in situ (DCIS) was detected. Re-excision was performed in 4 (26.6%) patients, and mastectomy was performed in 2 (13.3%) patients with malignancy. The median tumor diameter of malignant lesions was 9 mm. The mean follow-up period of the patients was found to be 42.46+16.44 months.\u0000Conclusion: Suspicious microcalcification areas detected in mammographic examinations, lack of ultrasonographic visibility, and biopsy with another minimally invasive method should be excised after marking with a stereotactic wire. This procedure is an effective method that allows early diagnosis of malignancies.","PeriodicalId":42642,"journal":{"name":"European Journal of Therapeutics","volume":"405 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2023-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77744212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of Cervical Posture, Sleep Quality and Perceived Health Risk in Technology Addicted Adolescents and Young Adults: A Comparative Study 科技成瘾青少年与青少年颈椎姿势、睡眠质量与健康风险感知的比较研究
European Journal of Therapeutics Pub Date : 2023-09-09 DOI: 10.58600/eurjther1784
Tuba Maden, Emir Ibrahim Isik
{"title":"Investigation of Cervical Posture, Sleep Quality and Perceived Health Risk in Technology Addicted Adolescents and Young Adults: A Comparative Study","authors":"Tuba Maden, Emir Ibrahim Isik","doi":"10.58600/eurjther1784","DOIUrl":"https://doi.org/10.58600/eurjther1784","url":null,"abstract":"Objective: The aim of this study was to compare the cervical posture, sleep quality, and perceived health risk of technology-addicted adolescents, young adults and their controls. Methods: Adolescents and young-adults participants (n=160) were divided into four groups as addicted and non-addicted according to their age and Technology Addiction Scale scores. Cervical posture assessments were obtained by photographic analysis. Craniovertebral (CVA), craniohorizontal (CHA) and sagittal shoulder angle (SSA) values were recorded. Sleep quality was assessed with the Pittsburg Sleep Quality Scale. Participants' Perceived Health Risk was evaluated with a single-item, five-point Likert questionnaire. Results: The addicted participants had worse CVA than both their controls (p=0.000). Participants' CHA and SSA angles were similar in addicted groups (p=0.710 and p=0.612, respectively). Addicted adolescents had worse sleep quality than addicted young-adults (p=0.005). Perceived Health Risk is low level in all groups and there were no significant differences (p=0.055). Conclusion: Technology addiction affects the adolescent group more negatively than the young-adults. In the sample of adolescents and young-adults, individuals did not perceive excessive use of technological tools as a risk factor for their health. The degradation of CVA due to overuse of technological tools precedes the degradation of CHA and SSA. This can be explained by the fact that CVA is a more general angle that includes both the head- neck position and the vertebrae. It is necessary for public health and future health expenditures to educate and raise awareness of the more vulnerable adolescent group.","PeriodicalId":42642,"journal":{"name":"European Journal of Therapeutics","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136107458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three-Dimensional (3D) Morphometric Analysis of Plegic and Healthy Feet of Patients with Stroke 脑卒中患者瘫痪与健康足部的三维形态计量学分析
IF 0.3
European Journal of Therapeutics Pub Date : 2023-09-05 DOI: 10.58600/eurjther1701
Mehmet Karagulle, Yilmaz Yildirim, Umut Ozsoy, Lütfi Süzen, Hatice IKIZLER MAY
{"title":"Three-Dimensional (3D) Morphometric Analysis of Plegic and Healthy Feet of Patients with Stroke","authors":"Mehmet Karagulle, Yilmaz Yildirim, Umut Ozsoy, Lütfi Süzen, Hatice IKIZLER MAY","doi":"10.58600/eurjther1701","DOIUrl":"https://doi.org/10.58600/eurjther1701","url":null,"abstract":"Objective: This study aimed to quantitatively assess the changes in foot morphology in stroke patients using 3D scanning and focused on parameters like foot volume, area, and the root mean square difference (RMS) values. The objective was to enhance our understanding of post-stroke foot morphology and its potential relevance for rehabilitation, especially in designing orthotic supports and specialized footwear for stroke patients.\u0000Methods: Our study involved fourteen right hemiplegia patients and twenty healthy subjects. Stroke patients were assessed using international scales. We utilized a 3D scanning device to digitize and examine the differences in foot morphology between hemiplegic and healthy subjects, analyzing the data on a computer platform.\u0000Results: In the context of post-stroke individuals with hemiplegic feet, our morphometric analysis revealed notable differences in foot area and foot volume when compared to their healthy counterparts. These distinctions extended to linear measurements encompassing foot length, foot width, instep height, bimalleolar width, and ball width. Significantly, RMS exhibited a substantial increase in the patient cohort compared to the healthy group (p<0.05). Our investigation also established correlations between these standing morphometric parameters and RMS alterations, with noteworthy coefficients for various parameters: RMS(Foot Length Difference, 0.41), RMS(Foot Width Difference, 0.45), RMS(Instep Height Difference, 0.58), RMS(Ball Width Difference, 0.58), RMS(Bimalleolar Width Difference, 0.19), RMS(Volume Difference, 0.74), and RMS(Area Difference, 0.62).\u0000Conclusion: This study suggests incorporating RMS values as a novel parameter in the evaluation process. We anticipate that these findings will have practical implications, particularly in designing orthotic supports, specialized footwear for stroke patients, and the formulation of tailored rehabilitation programs within clinical settings.","PeriodicalId":42642,"journal":{"name":"European Journal of Therapeutics","volume":"11 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2023-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88712104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In the Anatomic Studies, Is It Correct to Add an Artificial Intelligence Such as ChatGPT as a Co-Author? 在解剖学研究中,添加ChatGPT等人工智能作为合著者是否正确?
IF 0.3
European Journal of Therapeutics Pub Date : 2023-09-02 DOI: 10.58600/eurjther1826
Gökçe Bağcı Uzun
{"title":"In the Anatomic Studies, Is It Correct to Add an Artificial Intelligence Such as ChatGPT as a Co-Author?","authors":"Gökçe Bağcı Uzun","doi":"10.58600/eurjther1826","DOIUrl":"https://doi.org/10.58600/eurjther1826","url":null,"abstract":"Dear Editors,\u0000I follow your journal with pleasure. I enjoyed reading your articles on artificial intelligence [1,2]. I would like to share my ideas with you about the use of artificial intelligence, which many researchers are currently curious about.\u0000Health applications are being renewed day by day. New technology and new gains in treatment have made us curious about the use of artificial intelligence [3]. Health experts using methods such as machine learning and deep learning, which are sub-branches of artificial intelligence, are switching to new methods in processes such as diagnosis, treatment, rehabilitation, and health protection of diseases [4,5]. ChatGPT (Chat Generative Pre-trained Transformer), used in the studies and also added as a co-author, is ChatGPT, an artificial intelligence chatbot with the GPT-3.5.5 language model, which was released by the artificial intelligence research company OpenAI on November 30, 2022, and reached 1 million users in 5 days [3]. This robot can become a promising and powerful tool for tasks such as automatic drafting, article summarization, homework, and language translation, which can be useful for making writing work faster and easier in academic activities. Talan and Kalınkara [6] used ChatGPT in the Anatomy course and found that students performed better. Aktay et al. [7] stated that students found ChatGPT interesting and fun and that it increased students achievement. Saygın and Kabakcı [8] stated that the use of ChatGPT can be useful in information learning and in producing something new.\u0000On the other hand, in a few studies, the addition of artificial intelligence as a co-author has been stated to be worrying [1,9]. If the academician does not produce it himself, but the artificial intelligence he uses as a co-author does, it may create an obstacle in multidisciplinary studies. If ChatGPT is written instead of a collaborator when you want to study anatomy, we are concerned about the decrease in our assistants, students, and research scientists.\u0000As a result, ChatGPT can be used in the learning of the Anatomy course and can also be useful in increasing knowledge in academia, but I do not find it ethically correct for ChatGPT to do the work that master’s and doctoral students have done for years in master’s and doctoral studies in a short time. In addition, in the studies on Anatomy, while writing a scientist is a co-author, the inclusion of ChatGPT will pave the way for the production of studies without labor in a short time, and this will cause serious concerns in academia. It will save time in academia, but academics’ communication with each other will decrease, there will be no cooperation and multidisciplinary studies will decrease. Who will be responsible in case of any problems while participating as a co-author with ChatGPT? I think that the use of ChatGPT should be supervised and that it is worrying to be a co-author at the moment.\u0000Yours sincerely","PeriodicalId":42642,"journal":{"name":"European Journal of Therapeutics","volume":"29 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2023-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85933999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Karolinska Sleepiness Scale is not Associated with Obstructive Sleep Apnea Severity Indices in Male Taxi Drivers 卡罗林斯卡睡意量表与男性出租车司机阻塞性睡眠呼吸暂停严重程度指数无关
IF 0.3
European Journal of Therapeutics Pub Date : 2023-08-31 DOI: 10.58600/eurjther1794
Y. Çelik
{"title":"Karolinska Sleepiness Scale is not Associated with Obstructive Sleep Apnea Severity Indices in Male Taxi Drivers","authors":"Y. Çelik","doi":"10.58600/eurjther1794","DOIUrl":"https://doi.org/10.58600/eurjther1794","url":null,"abstract":"Objective: In the current study, we aimed to evaluate the diagnostic utility of the Karolinska Sleepiness Scale (KSS) for obstructive sleep apnea (OSA) in taxi drivers.\u0000Methods: Forty male professional taxi drivers who participated in a driving simulator experiment in the sleep laboratory were included in the current study. All participants were asked to fill out the KSS before and after a 50-minute driving simulator task in the morning after overnight polysomnography (PSG) in the hospital. OSA was defined as an apnea-hypopnea-index (AHI) 15 events/hour on the PSG. Excessive daytime sleepiness (EDS) was defined as KSS score of at least 6.\u0000Results: In all, only 3 cases fulfilled the criteria for EDS before the driving whereas 13 cases were sleepy after the task was completed (p <0.001). No significant association was found between KSS scores after the task and the PSG variables including total sleep time, time spent in delta sleep and REM sleep as well as OSA severity indices AHI and Oxygen Desaturation Index (ODI). The agreement between OSA and sleepiness on the KSS was calculated as 0.21 (p=0.07) indicating a very weak association. The KSS has a sensitivity of 24.1%, a specificity of 45.5%, a positive predictive value of 53.9%, a negative predictive value of 30.0%, an accuracy of 46.6% for the OSA diagnosis. The area under the curve was 0.57 (95% CI 0.39 – 0.74) for the AHI and 0.56 (95% CI 0.39 – 0.73) for the ODI, confirming a very poor performance of the KSS scores to predict AHI and ODI.\u0000Conclusion: The KSS is not associated with the severity of the OSA indices in male taxi drivers. Objective measurements of EDS are warranted for a more precise evaluation of fitness to drive in professional drivers.","PeriodicalId":42642,"journal":{"name":"European Journal of Therapeutics","volume":"98 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2023-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81377837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of Mortality in Pulmonary Embolism: A Real-Life Study 肺栓塞死亡率的预测因素:一项现实生活研究
IF 0.3
European Journal of Therapeutics Pub Date : 2023-08-31 DOI: 10.58600/eurjther1818
Fusun Fakili, M. Taylan, İrem Zehra Bilgiç, İ. Düzen
{"title":"Predictors of Mortality in Pulmonary Embolism: A Real-Life Study","authors":"Fusun Fakili, M. Taylan, İrem Zehra Bilgiç, İ. Düzen","doi":"10.58600/eurjther1818","DOIUrl":"https://doi.org/10.58600/eurjther1818","url":null,"abstract":"Objective: The primary aim of this study was to investigate the mortality and associated factors in patients with pulmonary embolism.\u0000Methods: A retrospective analysis was performed on adult patients with pulmonary embolism who applied to X University Hospital between January 1, 2017, and January 1, 2023. All-cause mortality and related factors in pulmonary embolism patients were determined.\u0000Results: This study included 152 patients with a median age of 59 years and 81 (53.3%) women. The all-cause mortality rate was 25.7%, and pulmonary embolism-related deaths were 1.3%. Age (p<0.001), chronic obstructive pulmonary disease (COPD) (p=0.013), heart failure (p=0.018), atrial fibrillation (p=0.015), massive pulmonary embolism (p=0.029), hemoglobin level (p<0.001) and NT-Pro BNP level (p<0.001) were significantly associated with increased all-cause mortality. In binary logistic regression analysis, for each unit of increasing pulmonary embolism severity index (PESI) score, mortality increased 2.2-fold (95% CI:1.03-5.09), massive PTE 1.6-fold (95% CI:0.14-17.86), anticoagulant duration (daily) 0.98-fold (95% CI:0.98-0.99) and Hb level (per unit Hb reduction) 0.67-fold (95% CI:0.45-1.02) mortality was increasing. There was no statistical difference between the number of hospitalization days for patients with low and high PESI and simplified PE severity index (sPESI) scores.\u0000Conclusions: All-cause mortality in patients with pulmonary embolism increased with age, cardiac diseases, and COPD comorbidities. The PESI and sPESI scores used in the acute phase of PTE were found to be highly reliable in predicting all-cause mortality in PE patients. The diagnosis of massive PE and elevated NT-proBNP levels, a marker of right ventricular dysfunction, were factors that increased mortality.","PeriodicalId":42642,"journal":{"name":"European Journal of Therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2023-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79911139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Welcome to the New Issue (Vol: 29, No: 3, 2023) and Current News of the European Journal of Therapeutics 欢迎来到《欧洲治疗学杂志》新一期(第29卷,第3期,2023年)和最新消息
IF 0.3
European Journal of Therapeutics Pub Date : 2023-08-28 DOI: 10.58600/eurjther1795
Ayşe Balat, Ş. Eren, M. Menzilcioğlu, I. Bahsi, İlkay Doğan, A. Acıduman, Bilal Çiğ, Tsvetoslav Georgiev, R. Grillo, F. Govsa, D. Kaplan, M. Karadağ, M. Karaoğlan, Özgür Kasapçopur, Waqar M. Naqvi, A. Nasimi, V. Nedzvetsky, Raphael Olszewski, Janusz Ostrowski, A. Özçelik, Harry Pantazopoulos, M. Piagkou, H. Resić, A. R. A. Rodrigues, Domenico Santoro, Ghada Shahrour, O. Taydaş, G. Tsoucalas, H. Yıldız, B. Yilmaz Furtun, M. Zdilla, Joseph Schmidt
{"title":"Welcome to the New Issue (Vol: 29, No: 3, 2023) and Current News of the European Journal of Therapeutics","authors":"Ayşe Balat, Ş. Eren, M. Menzilcioğlu, I. Bahsi, İlkay Doğan, A. Acıduman, Bilal Çiğ, Tsvetoslav Georgiev, R. Grillo, F. Govsa, D. Kaplan, M. Karadağ, M. Karaoğlan, Özgür Kasapçopur, Waqar M. Naqvi, A. Nasimi, V. Nedzvetsky, Raphael Olszewski, Janusz Ostrowski, A. Özçelik, Harry Pantazopoulos, M. Piagkou, H. Resić, A. R. A. Rodrigues, Domenico Santoro, Ghada Shahrour, O. Taydaş, G. Tsoucalas, H. Yıldız, B. Yilmaz Furtun, M. Zdilla, Joseph Schmidt","doi":"10.58600/eurjther1795","DOIUrl":"https://doi.org/10.58600/eurjther1795","url":null,"abstract":"Dear Colleagues,\u0000We are delighted to share another issue (September 2023, Volume 29, Issue 3) of the European Journal of Therapeutics (Eur J Ther). We believe this issue’s valuable and exciting works will be read with interest. As you will notice at first glance, you will see that this issue contains many editorials and letters to the editor, unlike the previous issues. As the new editorial team, we aim to publish current developments, interesting notes, or important historical anecdotes in medicine as Editorials, Special Editorials, or Letters to the Editor. We would like to inform you that you can submit all of your articles that meet these criteria to our journal. In this editorial, we would like to share the developments that we think are important for Eur J Ther, since our previous editorial [1].\u0000First, we would like to share that the Eur J Ther is approved for inclusion in ERIH PLUS [2]. Moreover, the Eur J Ther now also appears in the Journal Section of the ResearchGate [3]. In this way, it will be possible to follow the Eur J Ther through ResearchGate. We wish to inform you that our editorial team is diligently striving to deliver enhanced advancements in the forthcoming editions. Another significant development is that an application to the Index Copernicus was submitted for the Eur J Ther on July 31, 2023 [4].\u0000In the previous issue, it was reported that some of the cited references made to the previous articles published in the Eur J Ther were not reflected in the Web of Science, and applications via “data changes form” were made to correct them [1]. Most of these applications have been completed, updated in the Web of Science database, and corrected missing references. With these corrections and new citations in the last three to four months, the average per-item value (total number of citations for all articles divided by the number of articles) of the Eur J Ther has increased from 0.52 to 0.78 [5]. In addition, the journal’s H-Index has risen from 8 to 10. The current metrics of Eur J Ther in the Web of Science are as follows, as of August 16, 2023 [5].\u0000\u0000Total number of publications: 800 (between 2007 to 2023)\u0000Citing Articles (total): 593\u0000Citing Articles (without self-citations): 558\u0000Times Cited (total): 620\u0000Times Cited (without self-citations): 570\u0000Average per item: 0.78 (620/800)\u0000H-Index: 10\u0000\u0000Although these metrics may be insufficient for Eur J Ther, which has been published for over thirty years, we, the New Editorial Team, anticipate that we can achieve better levels in the long run with our updated policies.\u0000Another significant development is that the Journal Impact Factor value of the Eur J Ther was calculated for the first time, and this value was 0.3. As is known, the Web of Science calculated Journal Impact Factors for the first time for journals in the E-SCI index as of 2023 [6]. Although a Journal Impact Factor of 0.3 is not satisfactory, it is not bad for a journal whose Journal Impact Factor is calculated for the first t","PeriodicalId":42642,"journal":{"name":"European Journal of Therapeutics","volume":"4 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2023-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80870975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信